{"id":"W6986370126","doi":"","title":"Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Trastuzumab; Breast cancer; Metastatic breast cancer; Disease; Clinical trial; Neratinib; Monoclonal antibody","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004652418,0.0002703624,0.0007069262,0.0007573864,0.0002076349,0.002010957,0.0006798501,0.001982601,0.005605125],"category_scores_gemma":[0.008292356,0.0001140313,0.0004712406,0.0009012385,0.000503212,0.001303995,0.000556219,0.001594847,0.0008813231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001386581,"about_ca_system_score_gemma":0.0024258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007339732,"about_ca_topic_score_gemma":0.002158686,"domain_scores_codex":[0.998406,0.0008475757,0.0001522584,0.0000724552,0.0004303472,0.00009139755],"domain_scores_gemma":[0.9957613,0.002736885,0.0005745871,0.00004928595,0.0005791489,0.0002987462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001033646,0.000139627,0.0008618069,0.003751132,0.0001305445,0.0007972528,0.00005836161,0.001217994,0.00137881,0.01132937,0.04983031,0.9294711],"study_design_scores_gemma":[0.001626719,0.002710212,0.007510663,0.01587502,0.0005068508,0.006727067,0.0002961433,0.002880969,0.002040336,0.02299583,0.9367515,0.00007867906],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004324449,0.9279764,0.0008493678,0.05517862,0.0008671565,0.00008787964,0.00009328618,0.00001571489,0.01060714],"genre_scores_gemma":[0.04519331,0.9329007,0.00210519,0.01160914,0.003600853,0.000200008,0.0001600029,0.00001348593,0.00421736],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005605125,"threshold_uncertainty_score":0.02460462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3142344266754238,"score_gpt":0.6089967220706151,"score_spread":0.2947622953951912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}